KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Goodwill: 2020-2025

Historic Goodwill for AbCellera Biologics (ABCL) over the last 5 years, with Sep 2025 value amounting to $47.8 million.

  • AbCellera Biologics' Goodwill changed negligibly% to $47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.8 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $47.8 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, AbCellera Biologics' Goodwill is $47.8 million, which was down 0.00% from $47.8 million recorded in Q2 2025.
  • Over the past 5 years, AbCellera Biologics' Goodwill peaked at $49.5 million during Q3 2021, and registered a low of $31.5 million during Q1 2021.
  • Moreover, its 3-year median value for Goodwill was $47.8 million (2025), whereas its average is $47.8 million.
  • Its Goodwill has fluctuated over the past 5 years, first skyrocketed by 51.77% in 2021, then dropped by 3.34% in 2022.
  • Quarterly analysis of 5 years shows AbCellera Biologics' Goodwill stood at $47.8 million in 2021, then remained steady at $47.8 million in 2022, then remained steady at $47.8 million in 2023, then remained steady at $47.8 million in 2024, then remained steady at $47.8 million in 2025.
  • Its last three reported values are $47.8 million in Q3 2025, $47.8 million for Q2 2025, and $47.8 million during Q1 2025.